The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistance

被引:147
作者
Gifford, Robert J. [1 ]
Liu, Tommy F. [1 ]
Rhee, Soo-Yon [1 ]
Kiuchi, Mark [1 ]
Hue, Stephane [2 ]
Pillay, Deenan [2 ,3 ]
Shafer, Robert W. [1 ]
机构
[1] Stanford Univ, Dept Med, Div Infect Dis, Stanford, CA 94305 USA
[2] UCL, Dept Infect, London WC1E 6BT, England
[3] Hlth Protect Agcy, Ctr Infect, Colindale, England
关键词
REVERSE-TRANSCRIPTASE; EPIDEMIOLOGIC SURVEILLANCE; ANTIRETROVIRAL TREATMENT; SEQUENCE; TRANSMISSION; MUTATIONS; PROTEASE; EUROPE;
D O I
10.1093/bioinformatics/btp134
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The calibrated population resistance (CPR) tool is a web-accessible program for performing standardized genotypic estimation of transmitted HIV-1 drug resistance. The program is linked to the Stanford HIV drug resistance database and can additionally perform viral genotyping and algorithmic estimation of resistance to specific antiretroviral drugs.
引用
收藏
页码:1197 / 1198
页数:2
相关论文
共 19 条
[1]  
Bennett DE, 2008, ANTIVIR THER, V13, P25
[2]  
Bennett DE, 2008, ANTIVIR THER, V13, P1
[3]  
Bertagnolio S, 2007, ANTIVIR THER, V12, P107
[4]  
Burns S, 2007, AIDS, V21, P1035, DOI 10.1097/QAD.0b013e3280b07761
[5]   Sequence editing by Apolipoprotein B RNA-editing catalytic component-B and epidemiological surveillance of transmitted HIV-1 drug resistance [J].
Gifford, Robert J. ;
Rhee, Soo-Yon ;
Eriksson, Nicolas ;
Liu, Tommy F. ;
Kiuchi, Mark ;
Das, Amar K. ;
Shafer, Robert W. .
AIDS, 2008, 22 (06) :717-725
[6]   The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings [J].
Gilks, Charles F. ;
Crowley, Siobhan ;
Ekpini, Rene ;
Gove, Sandy ;
Perriens, Jos ;
Souteyrand, Yves ;
Sutherland, Don ;
Vitoria, Marco ;
Guerma, Teguest ;
De Cock, Kevin .
LANCET, 2006, 368 (9534) :505-510
[7]   APOBEC-mediated viral restriction: not simply editing? [J].
Holmes, Rebecca K. ;
Malim, Michael H. ;
Bishop, Kate N. .
TRENDS IN BIOCHEMICAL SCIENCES, 2007, 32 (03) :118-128
[8]  
Huang XQ, 1996, COMPUT APPL BIOSCI, V12, P497
[9]   Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1-infected subjects [J].
Kuritzkes, Daniel R. ;
Lalama, Christina M. ;
Ribaudo, Heather J. ;
Marcial, Michelle ;
Meyer, William A., III ;
Shikuma, Cecilia ;
Johnson, Victoria A. ;
Fiscus, Susan A. ;
D'Aquila, Richard T. ;
Schackman, Bruce R. ;
Acosta, Edward P. ;
Gulick, Roy M. .
JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (06) :867-870
[10]   Antiretroviral-drug resistance among patients recently infected with HIV [J].
Little, SJ ;
Holte, S ;
Routy, JP ;
Daar, ES ;
Markowitz, M ;
Collier, AC ;
Koup, RA ;
Mellors, JW ;
Connick, E ;
Conway, B ;
Kilby, M ;
Wang, L ;
Whitcomb, JM ;
Hellmann, NS ;
Richman, DD .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (06) :385-394